Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia
Abstract Converging findings have established that the endocannabinoid (eCB) system serves as a possible target for the development of new…
Abstract Converging findings have established that the endocannabinoid (eCB) system serves as a possible target for the development of new…
Abstract Background: Adolescent cannabinoid exposure can have long-lasting effects on the brain, particularly in the prefrontal cortex, where the reelin…
Abstract Cannabis sativa L. contains numerous compounds with antioxidant and anti-inflammatory properties, including the flavonoids and the cannabinoids, particularly Δ-9-tetrahydrocannabinol…
Abstract Background: Substance use induces large economic and societal costs in the U.S. Understanding the change in substance use behaviors…
Abstract Background: Cannabinoid-based medicines (CBMs) are being used widely in older people. However, information on the incidence of adverse events…
Abstract Background: Tetrahydrocannabivarin (THCV) is a phytocannabinoid commonly found in cannabis with potential pharmacological properties; however, its post-acute pharmacokinetics (PK)…
Abstract The present studies were undertaken to understand the effects of the commonly used nutraceutical PEA on brain function and…
Abstract Background: The dual diagnosis of cannabis use disorder (CUD) and severe mental disorder (SMD) results in clinically complex individuals.…
Abstract Mounting evidence demonstrates that cannabinoids have anti-cancer properties. The mechanism by which the cannabinoids induce cell death is still…
Abstract Introduction: Cannabinoids are reported to suppress the growth of ovarian cancer cells, but it is unclear whether structural modifications…